Document is current
Any future updates will be listed below
-
Authors
Tan, Xi https://orcid.org/0000-0002-2409-5927
Brady, Brenna L.
Xie, Lin
Paprocki, Yurek https://orcid.org/0000-0002-5435-5179
-
Funding
Funding for this research was provided by:
Novo Nordisk Inc.
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 10 April 2025
First Online: 16 May 2025
Declarations
:
: Brenna L. Brady is employed by Merative, which received funding from Novo Nordisk to conduct this analysis. Xi Tan and Lin Xie are employed by Novo Nordisk Inc. Yurek Paprockic is employed by Novo Nordisk Inc. and holds stock/stock options in Novo Nordisk.
: All database records are de-identified and fully compliant with US patient confidentiality requirements, including the Health Insurance Portability and Accountability Act (HIPAA) of 1996. As this study used only de-identified patient records and did not involve the collection, use, or transmittal of individually identifiable data, institutional review board approval was not necessary.
